Deutsche Bank
PRME icon

Deutsche Bank’s Prime Medicine PRME Stock Holding History

Deutsche Bank’s Portfolio PRME Stock Details PRME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$422K Sell
114,472
-42,968
-27% -$143K ﹤0.01% 2863
2026
Q1 		$548K Buy
157,440
+9,497
+6% +$36.1K ﹤0.01% 2530
2025
Q4 		$513K Buy
147,943
+15,174
+11% +$67.5K ﹤0.01% 2555
2025
Q3 		$736K Buy
132,769
+7,324
+6% +$29.8K ﹤0.01% 2343
2025
Q2 		$310K Sell
125,445
-1,401
-1% -$2.16K ﹤0.01% 2714
2025
Q1 		$252K Buy
126,846
+46,011
+57% +$117K ﹤0.01% 2846
2024
Q4 		$236K Sell
80,835
-34,072
-30% -$120K ﹤0.01% 3023
2024
Q3 		$445K Sell
114,907
-346,088
-75% -$1.6M ﹤0.01% 2523
2024
Q2 		$2.37M Buy
460,995
+440,280
+2,125% +$2.67M ﹤0.01% 1558
2024
Q1 		$145K Buy
20,715
+614
+3% +$4.66K ﹤0.01% 3002
2023
Q4 		$178K Sell
20,101
-454
-2% -$3.5K ﹤0.01% 2941
2023
Q3 		$196K Buy
20,555
+2,743
+15% +$35.6K ﹤0.01% 2797
2023
Q2 		$261K Buy
17,812
+6,952
+64% +$97.1K ﹤0.01% 2734
2023
Q1 		$134K Buy
10,860
+6,387
+143% +$104K ﹤0.01% 3198
2022
Q4 		$83.1K Buy
+4,473
New +$80.8K ﹤0.01% 3413

Other funds holding PRME

AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Deutsche Bank's PRME Position: Q2 2026 in Review

Deutsche Bank reduced its Prime Medicine (PRME) stake by 27% in Q2 2026, selling an estimated $143K and leaving 114,472 shares worth $422K. The position accounts for ﹤0.01% of the portfolio, ranked #2863.

Deutsche Bank first reported a position in PRME in Q4 2022 and has held it in 15 quarters since. The position peaked at $2.37M in Q2 2024. 187 funds tracked by Wall St. Rank hold PRME as of Q2 2026.

  • Deutsche Bank held 114,472 shares of Prime Medicine worth $422K as of Q2 2026.
  • Deutsche Bank sold 42,968 Prime Medicine shares in Q2 2026, an estimated $143K.
  • Prime Medicine made up ﹤0.01% of Deutsche Bank's portfolio in Q2 2026, its #2863 holding.
  • Deutsche Bank first reported a position in Prime Medicine in Q4 2022 and has held it in 15 quarters since.
  • Deutsche Bank's Prime Medicine position peaked at $2.37M in Q2 2024.
  • 187 funds tracked by Wall St. Rank held Prime Medicine as of Q2 2026.

Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.